1 false false false false false false false false false false true false false false false true true No description of principal activity 2024-08-01 Sage Accounts Production Advanced 2025 - FRS102_2025 xbrli:pure xbrli:shares iso4217:GBP 14208534 2024-08-01 2025-07-31 14208534 2025-07-31 14208534 2024-07-31 14208534 2023-08-01 2024-07-31 14208534 2024-07-31 14208534 2023-07-31 14208534 bus:LeadAgentIfApplicable 2024-08-01 2025-07-31 14208534 bus:Director1 2024-08-01 2025-07-31 14208534 core:WithinOneYear 2025-07-31 14208534 core:WithinOneYear 2024-07-31 14208534 core:AfterOneYear 2025-07-31 14208534 core:AfterOneYear 2024-07-31 14208534 core:ShareCapital 2025-07-31 14208534 core:ShareCapital 2024-07-31 14208534 core:RetainedEarningsAccumulatedLosses 2025-07-31 14208534 core:RetainedEarningsAccumulatedLosses 2024-07-31 14208534 bus:SmallEntities 2024-08-01 2025-07-31 14208534 bus:AuditExemptWithAccountantsReport 2024-08-01 2025-07-31 14208534 bus:SmallCompaniesRegimeForAccounts 2024-08-01 2025-07-31 14208534 bus:PrivateLimitedCompanyLtd 2024-08-01 2025-07-31 14208534 bus:FullAccounts 2024-08-01 2025-07-31
COMPANY REGISTRATION NUMBER: 14208534
Kanso Skin Clinic Ltd
Filleted Unaudited Financial Statements
31 July 2025
Kanso Skin Clinic Ltd
Financial Statements
Year ended 31 July 2025
Contents
Page
Chartered certified accountants report to the director on the preparation of the unaudited statutory financial statements
1
Statement of financial position
2
Notes to the financial statements
4
Kanso Skin Clinic Ltd
Chartered Certified Accountants Report to the Director on the Preparation of the Unaudited Statutory Financial Statements of Kanso Skin Clinic Ltd
Year ended 31 July 2025
As described on the statement of financial position, the director of the company is responsible for the preparation of the financial statements for the year ended 31 July 2025, which comprise the statement of financial position and the related notes. You consider that the company is exempt from an audit under the Companies Act 2006. In accordance with your instructions we have compiled these financial statements in order to assist you to fulfil your statutory responsibilities, from the accounting records and from information and explanations supplied to us.
VAGHELA & CO. (SERVICES) LTD. Chartered Certified Accountants
P.O. Box 10901 Birmingham B1 1ZQ
31 July 2026
Kanso Skin Clinic Ltd
Statement of Financial Position
31 July 2025
2025
2024
Note
£
£
£
£
Current assets
Debtors
5
8,810
1,000
Cash at bank and in hand
1,145
10,275
-------
--------
9,955
11,275
Creditors: amounts falling due within one year
6
3,400
2,800
-------
--------
Net current assets
6,555
8,475
-------
-------
Total assets less current liabilities
6,555
8,475
Creditors: amounts falling due after more than one year
7
6,200
6,200
-------
-------
Net assets
355
2,275
-------
-------
Capital and reserves
Called up share capital
1,000
1,000
Profit and loss account
( 645)
1,275
-------
-------
Shareholders funds
355
2,275
-------
-------
These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with Section 1A of FRS 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland'.
In accordance with section 444 of the Companies Act 2006, the statement of income and retained earnings has not been delivered.
For the year ending 31 July 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
Director's responsibilities:
- The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476 ;
- The director acknowledges her responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of financial statements .
Kanso Skin Clinic Ltd
Statement of Financial Position (continued)
31 July 2025
These financial statements were approved by the board of directors and authorised for issue on 31 July 2026 , and are signed on behalf of the board by:
Mrs S. Sharma
Director
Company registration number: 14208534
Kanso Skin Clinic Ltd
Notes to the Financial Statements
Year ended 31 July 2025
1. General information
The company is a private company limited by shares, registered in England and Wales. The address of the registered office is 37 Church Road, Birmingham, B26 3UF, Engand.
2. Statement of compliance
These financial statements have been prepared in compliance with Section 1A of FRS 102, 'The Financial Reporting Standard applicable in the UK and the Republic of Ireland'.
3. Accounting policies
Basis of preparation
The financial statements have been prepared on the historical cost basis, as modified by the revaluation of certain financial assets and liabilities and investment properties measured at fair value through profit or loss.
The financial statements are prepared in sterling, which is the functional currency of the entity.
Disclosure exemptions
The entity satisfies the criteria of being a qualifying entity as defined in FRS 102. As such, advantage has been taken of the following disclosure exemptions available under paragraph 1.12 of FRS 102: (a) No cash flow statement has been presented for the company. (b) Disclosures in respect of financial instruments have not been presented.
Revenue recognition
Turnover is measured at the fair value of the consideration received or receivable for goods supplied and services rendered, net of discounts and Value Added Tax. Revenue from the sale of goods is recognised when the significant risks and rewards of ownership have transferred to the buyer (usually on despatch of the goods); the amount of revenue can be measured reliably; it is probable that the associated economic benefits will flow to the entity; and the costs incurred or to be incurred in respect of the transactions can be measured reliably.
Income tax
The taxation expense represents the aggregate amount of current and deferred tax recognised in the reporting period. Tax is recognised in profit or loss, except to the extent that it relates to items recognised in other comprehensive income or directly in equity. In this case, tax is recognised in other comprehensive income or directly in equity, respectively. Current tax is recognised on taxable profit for the current and past periods. Current tax is measured at the amounts of tax expected to pay or recover using the tax rates and laws that have been enacted or substantively enacted at the reporting date.
Deferred tax is recognised in respect of all timing differences at the reporting date. Unrelieved tax losses and other deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date that are expected to apply to the reversal of the timing difference.
Financial instruments
Financial instruments are classified and accounted for, according to the substance of the contractual arrangement, as either financial assets, financial liabilities or equity instruments. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities.
4. Employee numbers
The average number of persons employed by the company during the year amounted to 1 (2024: Nil).
5. Debtors
2025
2024
£
£
Other debtors
8,810
1,000
-------
-------
6. Creditors: amounts falling due within one year
2025
2024
£
£
Other creditors
3,400
2,800
-------
-------
7. Creditors: amounts falling due after more than one year
2025
2024
£
£
Other creditors
6,200
6,200
-------
-------
8. Director's advances, credits and guarantees
At 31st Jul 2025, other debtors include the following amounts due from the director:- Mrs S. Sharma £7,800 The loans are interest free and repayable on demand